Premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Oral administration of 1000 mg Royal jelly capsule for 2 menstrual cycle. Intervention 2: placebo.
Prevention
Placebo
Oral administration of 1000 mg Royal jelly capsule for 2 menstrual cycle
placebo
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Research Institute for Islamic & Complementary Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 20 and 35 years old; not taking any medicine; having symptoms in 2 past cycles; not taking any complements; no allergy to honey or Royal jelly; no changes in diet & exercise program; not smoking, alcohol or drug usage Exclusion criteria: use of any kind of drug or therapy for symptom relief during the study intervention; side effects during intervention for example allergy; change in diet or physical exercise program during the study; any kind of crisis in participant or her family; not taking royale jelly or placebo more than 7 days in 2 cycles
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Premenstrual syndrome (screening). Timepoint: 2 menstrual cycles. Method of measurement: premenstural profile 2005 scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Premenstrual syndrome (prevention). Timepoint: during intervention for 2 cycles. Method of measurement: premenstrual profile 2005 scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSimin Taavoni
Nursing and Midwifery Faculty, Tehran University of Medical Sciences
Outcome results
None listed